[go: up one dir, main page]

DK1026170T3 - Erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler - Google Patents

Erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler

Info

Publication number
DK1026170T3
DK1026170T3 DK00400286T DK00400286T DK1026170T3 DK 1026170 T3 DK1026170 T3 DK 1026170T3 DK 00400286 T DK00400286 T DK 00400286T DK 00400286 T DK00400286 T DK 00400286T DK 1026170 T3 DK1026170 T3 DK 1026170T3
Authority
DK
Denmark
Prior art keywords
preparation
erythromycin derivatives
drugs
processes
halo
Prior art date
Application number
DK00400286T
Other languages
Danish (da)
English (en)
Inventor
Alexis Denis
Claude Fromentin
Bertrand Heckmann
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1026170T3 publication Critical patent/DK1026170T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00400286T 1999-02-04 2000-02-03 Erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler DK1026170T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9901292A FR2789392B1 (fr) 1999-02-04 1999-02-04 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
DK1026170T3 true DK1026170T3 (da) 2003-05-05

Family

ID=9541593

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00400286T DK1026170T3 (da) 1999-02-04 2000-02-03 Erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler

Country Status (8)

Country Link
US (1) US6313101B1 (de)
EP (1) EP1026170B1 (de)
JP (2) JP5019665B2 (de)
AT (1) ATE231160T1 (de)
DE (1) DE60001182T2 (de)
DK (1) DK1026170T3 (de)
ES (1) ES2186615T3 (de)
FR (1) FR2789392B1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6484199A (en) * 1998-12-10 2000-06-26 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
CN1342163A (zh) 1999-01-27 2002-03-27 辉瑞产品公司 酮内酯类抗生素
SK15162001A3 (sk) 1999-05-24 2003-02-04 Pfizer Products Inc. Deriváty 13-metylerytromycínu
DE19948417A1 (de) * 1999-10-07 2001-04-19 Morphochem Ag Imidazol-Derivate und ihre Verwendung als Arzneimittel
ATE271062T1 (de) 2000-06-30 2004-07-15 Pfizer Prod Inc Makrolid-antibiotika
US20080287376A1 (en) * 2004-07-28 2008-11-20 Mohammad Salman Ketolide Derivatives as Antibacterial Agents
EP1807439A2 (de) * 2004-10-25 2007-07-18 Ranbaxy Laboratories Limited Ketolid-derivate als antibakterielle agentien
US9453042B2 (en) 2007-10-25 2016-09-27 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
WO2010048600A1 (en) 2008-10-24 2010-04-29 Cempra Pharmaceuticals, Inc. Methods for treating resistant diseases using triazole containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
CN108310000A (zh) 2009-09-10 2018-07-24 森普拉制药公司 治疗疟疾、结核病和mac疾病的方法
US9815863B2 (en) 2010-09-10 2017-11-14 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
CA2868262A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
AU2014239959A1 (en) 2013-03-14 2015-10-01 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
AU2014233240B2 (en) 2013-03-15 2018-08-09 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
CN104860943B (zh) * 2015-05-18 2017-11-17 上海毕路得医药科技有限公司 5,7‑二氯‑1h‑咪唑并[4,5‑b]吡啶的合成方法
CN106432383A (zh) * 2016-09-14 2017-02-22 重庆两江药物研发中心有限公司 索利霉素及其中间体的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2732023B1 (fr) * 1995-03-22 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2732684B1 (fr) * 1995-04-06 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
JP5019665B2 (ja) 2012-09-05
ATE231160T1 (de) 2003-02-15
DE60001182T2 (de) 2003-10-09
FR2789392A1 (fr) 2000-08-11
JP2000229993A (ja) 2000-08-22
JP5222348B2 (ja) 2013-06-26
EP1026170A1 (de) 2000-08-09
FR2789392B1 (fr) 2001-10-05
ES2186615T3 (es) 2003-05-16
JP2011136990A (ja) 2011-07-14
DE60001182D1 (de) 2003-02-20
EP1026170B1 (de) 2003-01-15
US6313101B1 (en) 2001-11-06

Similar Documents

Publication Publication Date Title
DK1026170T3 (da) Erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
WO2002100851A3 (en) Thiophene derivatives as antiviral agents for flavivirus infection
DK0968206T3 (da) N-heterocykliske derivater som NOS-inhibitorer
ATE324371T1 (de) N-substituierte heterocyclische nichtaryl- nmda/nr2b-antagonisten
DK0698606T3 (da) Azolylaminderivat
DE69820248D1 (de) Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben
BR0012451A (pt) Processo para a preparação de derivados de ácido 2-heterociclilmetil-benzóico
DK0773943T3 (da) Forbindelser, der er anvendelige som antiproliferative midler og garft-inhibitorer
DK0903347T3 (da) Hidtil ukendte cyclodepsipeptid PF1022-derivater
ATE278661T1 (de) Anthranilsäurederivate
EA200000826A1 (ru) Галоидированные производные амидиноаминокислот, применимые в качестве ингибиторов no-синтазы
AU9281198A (en) Benzofuran derivatives
DK1222159T3 (da) Mellemprodukter til fremstilling af et benzofuran- eller benzothiophenderivat, som er nitreret i position 5, og anvendelse heraf
ATE322487T1 (de) Hydroxamsäure-derivate
DK0601486T3 (da) Cis-epoxidderivater, der er egnede som irreversible HIV-proteaseinhibitorer, og fremgangsmåde og mellemprodukter til deres
BRPI0210746B8 (pt) derivados de 6-'2-(fosfonometóxi)alcóxi-pirimidina e seu método de preparação
DK0683170T3 (da) Glucopyranosidbenzothiophener
HRP20010798B1 (hr) Postupci priprave pesticidnih međuprodukata
NO996179L (no) Nye 1,2-ditiolanforbindelser, en fremgangsmÕte for deres fremstilling og farmasøytiske blandinger inneholdende disse
DE69706950D1 (de) Furoindolizine
DE60102113D1 (de) Ammonium-3,5,6-trihydroxyhexansäure-Derivate und Methoden zu ihrer Herstellung
DK1433480T3 (da) Lægemiddel indeholdende pyrimidin-derivat
ATE225789T1 (de) Loracarbef hydrochlorid c1-c3 alkohol-solvate und deren verwendungen
PT1140932E (pt) Derivados de 1,8-benzonaftiridina